PerkinElmer announces first commercial availability of newborn screening test for SCID
PerkinElmer announced the first commercially available screening test in the U.S. and Canada for Severe Combined Immunodeficiency, known as "Bubble Boy" disease. PerkinElmer has received market authorization from the FDA and Health Canada to offer the VICTOR™ EnLite™ and EnLite™ Neonatal TREC Kit. December 18, 2014